- Home
- AXSM vs TFSL Comparison
AXSM vs TFSL Comparison
Compare AXSM & TFSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- TFSL
- Stock Information
- Founded
- AXSM 2012
- TFSL 1938
- Country
- AXSM United States
- TFSL United States
- Employees
- AXSM N/A
- TFSL N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- TFSL Savings Institutions
- Sector
- AXSM Health Care
- TFSL Finance
- Exchange
- AXSM Nasdaq
- TFSL Nasdaq
- Market Cap
- AXSM 4.4B
- TFSL 3.5B
- IPO Year
- AXSM 2015
- TFSL 2007
- Fundamental
- Price
- AXSM $98.19
- TFSL $14.38
- Analyst Decision
- AXSM Strong Buy
- TFSL Hold
- Analyst Count
- AXSM 14
- TFSL 2
- Target Price
- AXSM $124.93
- TFSL $14.00
- AVG Volume (30 Days)
- AXSM 536.9K
- TFSL 300.5K
- Earning Date
- AXSM 11-12-2024
- TFSL 10-30-2024
- Dividend Yield
- AXSM N/A
- TFSL 7.88%
- EPS Growth
- AXSM N/A
- TFSL 7.69
- EPS
- AXSM N/A
- TFSL 0.28
- Revenue
- AXSM $338,457,000.00
- TFSL $304,660,000.00
- Revenue This Year
- AXSM $40.67
- TFSL N/A
- Revenue Next Year
- AXSM $69.27
- TFSL $6.83
- P/E Ratio
- AXSM N/A
- TFSL $51.50
- Revenue Growth
- AXSM 51.47
- TFSL N/A
- 52 Week Low
- AXSM $60.28
- TFSL $11.70
- 52 Week High
- AXSM $105.00
- TFSL $15.25
- Technical
- Relative Strength Index (RSI)
- AXSM 61.45
- TFSL 63.23
- Support Level
- AXSM $90.86
- TFSL $13.66
- Resistance Level
- AXSM $105.00
- TFSL $14.53
- Average True Range (ATR)
- AXSM 4.06
- TFSL 0.33
- MACD
- AXSM 0.44
- TFSL 0.04
- Stochastic Oscillator
- AXSM 64.04
- TFSL 91.80
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About TFSL TFS Financial Corporation
TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.